以岭药业：一粒“中国造”小药片，如何叩开国际市场的大门？

Core Viewpoint - Yiling Pharmaceutical is actively promoting the internationalization of traditional Chinese medicine (TCM) as a necessary evolution for survival and development in a competitive market [5][12]. Group 1: Company Growth and Internationalization - Yiling Pharmaceutical has expanded its presence to over 50 countries and regions, including Southeast Asia, North America, the Middle East, Africa, Eastern Europe, and South America [3]. - The company has been recognized as one of the "Top 100 Chinese Brand Values," "Top 20 Chinese Pharmaceutical Listed Companies," and "Top 10 Chinese Traditional Chinese Medicine Enterprises," reflecting its growth and competitiveness on the global stage [3]. - The company has established over 60 planting bases for authentic medicinal materials across more than 20 provinces in China to ensure product quality from the source [5]. Group 2: Innovative Research and Development - Yiling Pharmaceutical has developed a five-in-one operational model that integrates theory, clinical practice, research, industry, and education to foster a robust innovation ecosystem [5]. - The company collaborates with international research institutions, including Cardiff University, Leiden University, Harvard Medical School, and Duke University, conducting over 40 high-standard evidence-based medical studies and publishing more than 300 SCI papers [7][9]. - The establishment of the "Luo Disease Theory" framework has garnered significant attention and six national-level science and technology awards, enhancing the company's reputation in the industry [8][9]. Group 3: Market Expansion Strategies - Yiling Pharmaceutical employs a "dual-line parallel" strategy to navigate the complexities of international markets, focusing on academic promotion and tailored marketing strategies based on regional characteristics [12][14]. - The successful internationalization of the Lianhua Qingwen Capsule, which has become a staple in Thai households, exemplifies the company's effective market penetration strategies [15]. - The company aims to make its products accessible in chain pharmacies and supermarkets, targeting high-traffic demographics such as office workers and tourists [15]. Group 4: Future Aspirations - Yiling Pharmaceutical envisions becoming an influential innovative brand in the global TCM sector, emphasizing that internationalization is a new starting point rather than an endpoint [16].